IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Go back to IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

IGM Biosciences Inc. (IGMS) Tops Q4 EPS by 34c

March 30, 2023 4:12 PM EDT

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($1.19), $0.34 better than the analyst estimate of ($1.53). Revenue for the quarter came in at $372 thousand versus the consensus estimate of $304.78 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

... More